First Hawaiian Bank Has $1.20 Million Holdings in Danaher Co. (NYSE:DHR)

First Hawaiian Bank lifted its position in shares of Danaher Co. (NYSE:DHR) by 10.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,220 shares of the conglomerate’s stock after purchasing an additional 512 shares during the quarter. First Hawaiian Bank’s holdings in Danaher were worth $1,198,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. FMR LLC lifted its stake in shares of Danaher by 15.8% in the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after buying an additional 3,217,631 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Danaher by 22.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate’s stock worth $761,475,000 after acquiring an additional 563,546 shares during the last quarter. International Assets Investment Management LLC boosted its stake in Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after purchasing an additional 428,897 shares during the last quarter. Montrusco Bolton Investments Inc. increased its holdings in Danaher by 30.4% during the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after purchasing an additional 397,671 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its stake in shares of Danaher by 82.4% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 653,375 shares of the conglomerate’s stock worth $181,651,000 after purchasing an additional 295,187 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Danaher stock opened at $237.90 on Friday. The firm has a market capitalization of $171.83 billion, a P/E ratio of 45.40, a PEG ratio of 4.33 and a beta of 0.83. Danaher Co. has a one year low of $222.53 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The business has a fifty day moving average price of $235.93 and a 200-day moving average price of $253.88.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the previous year, the firm earned $2.02 EPS. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. As a group, equities research analysts forecast that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Analysts Set New Price Targets

DHR has been the subject of several recent research reports. Guggenheim initiated coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target for the company. UBS Group reduced their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. Barclays reduced their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Finally, KeyCorp boosted their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.